Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1000576-59-9

Post Buying Request

1000576-59-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1000576-59-9 Usage

Uses

7-Bromo-1-methyl-indazole acts as a reagent in the synthesis of cyclic benzimidazole derivatives which functions as protein kinase activators that are used in the treatment of type 2 diabetics, hyperglycemia and other related diseases.

Check Digit Verification of cas no

The CAS Registry Mumber 1000576-59-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,0,5,7 and 6 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1000576-59:
(9*1)+(8*0)+(7*0)+(6*0)+(5*5)+(4*7)+(3*6)+(2*5)+(1*9)=99
99 % 10 = 9
So 1000576-59-9 is a valid CAS Registry Number.

1000576-59-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 7-Bromo-1-methylindazole

1.2 Other means of identification

Product number -
Other names 7-Bromo-1-methyl-1H-indazole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1000576-59-9 SDS

1000576-59-9Relevant articles and documents

METHODS OF TREATING LIVER FIBROSIS USING CALPAIN INHIBITORS

-

Paragraph 0287-0289, (2020/01/24)

Disclosed herein are methods of treating liver fibrosis by administering calpain inhibitors to subjects in need thereof.

Indazole derivatives as CRF antagonists

-

Page/Page column 19, (2010/02/07)

This invention relates to compounds which are generally CRF-1 receptor antagonists and which are represented by Formula I or Formula II: wherein R3 is optionally substituted aryl or heteroaryl, R1 and R2 are as defined in

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1000576-59-9